Imprint Wealth LLC Makes New Investment in iShares Biotechnology ETF (NASDAQ:IBB)

Imprint Wealth LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, HoldingsChannel.com reports. The fund bought 1,489 shares of the financial services provider’s stock, valued at approximately $202,000.

Several other large investors also recently bought and sold shares of the stock. Glass Jacobson Investment Advisors llc lifted its stake in iShares Biotechnology ETF by 150.6% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 122 shares during the period. PCA Investment Advisory Services Inc. acquired a new stake in iShares Biotechnology ETF during the 2nd quarter valued at approximately $28,000. Values First Advisors Inc. acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $43,000. Horizon Bancorp Inc. IN acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at $44,000. Finally, Tennessee Valley Asset Management Partners acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at $44,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.7 %

IBB opened at $126.97 on Wednesday. The firm has a fifty day moving average price of $135.63 and a 200 day moving average price of $129.57. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a $0.126 dividend. This represents a $0.50 annualized dividend and a dividend yield of 0.40%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.